EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study

Jin Lee, Su Bum Park iD, Hyung Wook Kim, Hong Sub Lee, Sam Ryong Jee, Jong Hun Lee, Tae Oh Kim iD

Gastroenterology Research and Practice · 17.01.2022 · 2022 · 1-5

DOI: 10.1155/2022/9872230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Research and Practice, erschienen am 17.01.2022. Verfasst von Jin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 602-702, Republic o…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daewoong Pharmaceutical Company.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A substantial percentage of patients with ulcerative colitis (UC) have irritable bowel syndrome- (IBS-) like symptoms despite adequate treatment and endoscopic remission. In this study, we evaluated the clinical efficacy of probiotic therapy for residual IBS-like symptoms in patients with UC in endoscopic remission.

Methods

We conducted a multicenter, observational study between April 2018 and December 2020 across two university hospitals in Korea. Patients with UC whose IBS-like symptoms persisted during endoscopic remission were included in this study. Endoscopic remission was defined as a Mayo endoscopic score ≤ 1 , and IBS-like symptoms were defined as those meeting the ROME-IV diagnostic criteria. A Biotop capsule® (Lactobacillus acidophilus, 75 mg; Clostridium butyricum TO-A, 25 mg; Bacillus mesentericus TO-A, 25 mg; and Streptococcus faecalis T-110, 5 mg) was administered three times daily for one month. All patients completed bowel-related symptom questionnaires and short inflammatory bowel disease questionnaires (SIBDQs) at the start and end of the 4-week treatment period.

Results

A total of 43 patients were enrolled and analyzed. Statistically significant improvements from baseline were observed at the end of the 4-week treatment. The total SIBDQ score improved from 50.6 to 53.6 ( P = 0.005 ). SIBDQ scores of bowel function ( P = 0.018 ), systemic function ( P = 0.040 ), and social function ( P = 0.005 ) improved. Stool frequency and Bristol stool scale scores improved after probiotic therapy ( P < 0.05 ).

Conclusion

This study showed that probiotic administration improved bowel-related symptoms and quality of life in patients with UC whose IBS-like symptoms persisted during endoscopic remission. As this is an observational study and has no placebo-controlled arm, further prospective randomized controlled trials are needed to confirm these results.

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan 602-702, Republic of Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan 626-770, Republic of Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan 602-702, Republic of Korea.
  • Division of Gastroenterology, Department of Internal Medicine, Dong-A University Medical Center, Busan, Republic of Korea.

ORCID-Profile: Su Bum Park, Tae Oh Kim

Förderung

  • Daewoong Pharmaceutical Company

Zitieren

APA

Lee, J., Park, S. B., Kim, H. W., Lee, H. S., Jee, S. R., Lee, J. H., & Kim, T. O. (2022). Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study. Gastroenterology Research and Practice, 2022, 1-5. https://doi.org/10.1155/2022/9872230

Vancouver

Lee J, Park SB, Kim HW, Lee HS, Jee SR, Lee JH, et al. Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study. Gastroenterology Research and Practice. 2022;2022:1-5. doi:10.1155/2022/9872230

BibTeX
@article{Lee2022,
  author = {Lee, Jin and Park, Su Bum and Kim, Hyung Wook and Lee, Hong Sub and Jee, Sam Ryong and Lee, Jong Hun and Kim, Tae Oh},
  title = {Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study},
  journal = {Gastroenterology Research and Practice},
  year = {2022},
  volume = {2022},
  pages = {1--5},
  doi = {10.1155/2022/9872230}
}
Kostenlos starten →